Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
11:00 AM - Charmalot 2025
20
21
22
23
24
25
26
27
29
30
1
2
3
4
5
AI Leadership Strategy Summit
2025-09-18 - 2025-09-19    
12:00 am
AI is reshaping healthcare, but for executive leaders, adoption is only part of the equation. Success also requires making informed investments, establishing strong governance, and [...]
Charmalot 2025
2025-09-19 - 2025-09-21    
11:00 am
This is the CharmHealth annual user conference which also includes the CharmHealth Innovation Challenge. We enjoyed the event last year and we’re excited to be [...]
Civitas 2025 Annual Conference
2025-09-28 - 2025-09-30    
8:00 am
Civitas’ Annual Conference gathers hundreds of dedicated industry leaders, decision-makers, implementers, and innovators to explore key topics such as interoperability, data-driven quality improvement, social determinants [...]
Pathology Visions 2025
2025-10-05 - 2025-10-07    
8:00 am - 5:00 pm
Elevate Patient Care: Discover the Power of DP & AI Pathology Visions unites 800+ digital pathology experts and peers tackling today's challenges and shaping tomorrow's [...]
Events on 2025-09-18
Events on 2025-09-19
Charmalot 2025
19 Sep 25
CA
Events on 2025-09-28
Civitas 2025 Annual Conference
28 Sep 25
California
Events on 2025-10-05

Events

Blog Latest News

Global Cancer Tumor Profiling Market Growth by Regions, Technology and Analysis of Key Players

The demand for cancer profiling methods has witnessed significant growth over the years with seamlessly integrating next-generation sequencing (NGS) and in-situ hybridization for cancer profiling. In addition, cancer profiling for the detection of molecular & genetic level of cancers, and use of personalized and targeted approaches for treatment have propelled the market growth.

The Global Cancer Tumor Profiling Market  accounted to USD 25,318 million in 2016 growing at a CAGR of 18.3% during the forecast period of 2017 to 2024.

The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The potential of cancer profiling is extended from common cancers such as lymphoma and breast cancer to molecular profiling of lung cancer, prostate cancer and acute leukemia.

No. of Report Pages: 350

Request for Free Sample of Global Cancer Tumor Profiling Market Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-tumor-profiling-market

Major Market Drivers and Restraints:

  • Technological advancements for identifying the cancer tumors.
  • Increasing the cancer incidences.
  • Increase in the use of biomarkers in tumor profiling.
  • Availability of Funding for Cancer Research
  • Increase in demand for next generation sequencing technique in cancer profiling.
  • Lack of Skilled Professionals and Infrastructure
  • Growth in demand of personalized medicines

Browse Full Detailed with TOC, Sample, Inquiry, Expert and Global Cancer Tumor Profiling Market Visit @ http://databridgemarketresearch.com/reports/global-cancer-tumor-profiling-market/

Market Segmentation by Types

By Technique the market is segmented in

  • Genomics
  • Proteomics
  • Epigenetics
  • Metabolomics

By Application the market is segmented into

  • Personalized Medicine
  • Diagnostics
  • Biomarker Discovery
  • Prognostics
  • Research applications

On the basis of geography, global cancer tumor profiling market report covers data points for 28 countries across multiple geographies such as

  • North America & South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Top Key Players are:

tareIllumina, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, NeoGenomics Laboratories, Inc., HTG Molecular Diagnostics, Inc., Genomic Health Inc. , Caris Life Sciences, Helomics Corp., NanoString Technologies, Inc., Oxford Gene Technology, Abbott, BD, Hologic, Inc., Siemens Medical Solutions USA, Inc., Personal Genome Diagnostics, Inc., FOUNDATION MEDICINE, INC., Contextual Genomics, AGENDIA, Perthera, Inc., ApoCell, GenScript, Ribomed, Boreal Genomics Inc., Biotheranostics and Proteome Sciences among others.

For Any Query Speak to Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-cancer-tumor-profiling-market

Related Report

Global Computed Tomography Devices Market – Industry Trends and Forecast to 2024

Global Computed Tomography Devices Market, By product (Low Slice CT Scanner, Medium Slice CT Scanner, High Slice CT Scanner), by Application (Cardiovascular, Oncology, Neurovascular, Abdomen and Pelvic, Pulmonary Angiogram, Spinal, Musculoskeletal), by End-User (Hospitals, Diagnostics Centers), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Access Report: http://databridgemarketresearch.com/reports/global-computed-tomography-devices-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor: investors@databridgemarketresearch.com

Visit Blog: http://databridgemarketresearch.com/blog/

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research